| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| B7-H7 | HOT B77-H5257 | Human B7-H7 / HHLA2 Protein, Fc Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $340.00 100ug | |
| B7-H7 | HOTAvitag B77-H82E3 | Biotinylated Human B7-H7 / HHLA2 Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | |
| B7-H7 | Cynomolgus B7-H7 / HHLA2 Protein, His Tag, low endotoxin (MALS verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $340.00 100ug | ||
| B7-H7 | HOT B77-H52H6 | Human B7-H7 / HHLA2 Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $340.00 100ug | |
| B7-H7 | Avitag B77-C82E9 | Biotinylated Cynomolgus B7-H7 / HHLA2 Protein, His,Avitag™ | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | |
| B7-H7 | Avitag B77-H82F3 | Biotinylated Human B7-H7 / HHLA2 Protein, Fc,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | |
| B7-H7 | Avitag B77-H82F5 | Biotinylated Human B7-H7 / HHLA2 Protein, Fc,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| HBM-1020 | R-1020; HBM-1020 | Phase 1 Clinical | Harbour Biomed | Solid tumours | Details |
| NPX-372 | NPX372; NPX-372 | Phase 1 Clinical | NextPoint Therapeutics Inc | Solid tumours | Details |
| NPX-887 | NPX887; NPX-887 | Phase 1 Clinical | NextPoint Therapeutics Inc | Neoplasms; Solid tumours | Details |
